Barclays analyst Eric Beaumont maintains Eversource Energy (NYSE:ES) with a Equal-Weight and lowers the price target from $97 to $89.
Morgan Stanley Maintains Equal-Weight on Quest Diagnostics, Raises Price Target to $146
Morgan Stanley analyst Ricky Goldwasser maintains Quest Diagnostics (NYSE:DGX) with a Equal-Weight and raises the price target from $142 to $146.